Speaker

Bin Wu

Founder & Chief Executive Officer, Cytodigm

Bin Wu, Founder & Chief Executive Officer at Cytodigm, spoke at 7th Genome Editing Therapeutics Summit 2026 (Boston, United States of America, 29–30 Sept 2026) in the session “Workshop B: Advancing Extrahepatic Delivery to Improve Safety & Targeting for Genome Editing Therapeutics”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

7th Genome Editing Therapeutics Summit 2026
29–30 Sept 2026Boston, United States of America
- WorkshopWorkshop B: Advancing Extrahepatic Delivery to Improve Safety & Targeting for Genome Editing Therapeutics

More speakers at 7th Genome Editing Therapeutics Summit 2026

Alan Brooks
Senior Vice President, Research, Metagenomi Therapeutics
Wei-chiang chen
Associate Director, Sanofi
Ishani Dasgupta
Senior Scientist, AbbVie
Sarah Denny
Senior Director, Scribe Therapeutics
Kelan Hlavaty
Senior Director, Technical Operations, eGenesis Bio
Lalit Kumar
Senior Director, Clinical Bioanalytics & Translational Science, Beam Therapeutics

See all 19 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Bin Wu, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].